ROSS REYNOLDS: Open Payments
NPI 1104247410 · GRAND RAPIDS, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$227 in 6 payments from 6 companies in 2025. Trend: 2023 $311 · 2024 $361 · 2025 $227
Food & beverage: $213Education: $14
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 1 | $121 |
| Madrigal Pharmaceuticals | 1 | $33 |
| Ipsen Biopharmaceuticals, Inc | 1 | $22 |
| Janssen Biotech, Inc. | 1 | $21 |
| ABBVIE INC. | 1 | $18 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $14 |
Products named: Wegovy, REZDIFFRA, IQIRVO, TREMFYA, RINVOQ, EOHILIA.
Industry payments across MI — which companies pay providers there.
